Detalles de la búsqueda
1.
Phase II, randomized, open, controlled study of AS03-adjuvanted H5N1 pre-pandemic influenza vaccine in children aged 3 to 9 years: follow-up of safety and immunogenicity persistence at 24 months post-vaccination.
Influenza Other Respir Viruses
; 9(2): 68-77, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25652873
Resultados
1 -
1
de 1
1
Próxima >
>>